Finance

Beta
Lists
688581:SHA
Hangzhou Ags Medtech Co Ltd
CN¥55.90
+1.40%
(+0.77) 1D
Jun 15, 11:28:07 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688581...
Open
CN¥55.50
High
CN¥56.21
Low
CN¥55.35
Mkt. cap
4.47B
Avg. vol.
1.22M
Volume
193.48K
Dividend
1.86%
Quarterly dividend
CN¥0.26
Ex-dividend date
Jun 17, 2026
P/E ratio
20.24
52-wk high
CN¥88.96
52-wk low
CN¥52.40
EPS
CN¥2.76
No. of employees
807
Open
CN¥55.50
High
CN¥56.21
Low
CN¥55.35
Mkt. cap
4.47B
Avg. vol.
1.22M
Volume
193.48K
Dividend
1.86%
Quarterly dividend
CN¥0.26
Ex-dividend date
Jun 17, 2026
P/E ratio
20.24
52-wk high
CN¥88.96
52-wk low
CN¥52.40
EPS
CN¥2.76
No. of employees
807
News stories
From sources across the web
About Hangzhou Ags Medtech Co Ltd
CEO-
Employees807
FoundedDec 6, 2010
Headquarters-
SectorMedical device
Websitebioags.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
173.83M
156.90M
134.42M
140.44M
Cost of goods sold
51.13M
46.62M
38.49M
42.98M
Cost of revenue
51.13M
46.62M
38.49M
42.98M
Research and development expenses
21.46M
22.70M
18.74M
15.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32.26M
37.11M
31.44M
21.79M
Operating expense
60.36M
56.35M
59.25M
38.28M
Total operating expenses
111.48M
102.97M
97.74M
81.26M
Operating income
62.34M
53.92M
36.68M
59.18M
Other non operating income
-1.49M
-2.27M
2.11M
-5.62M
EBT including unusual items
82.84M
59.86M
53.06M
67.30M
EBT excluding unusual items
77.80M
64.48M
43.23M
65.30M
Income tax expense
13.07M
8.87M
8.63M
10.73M
Effective tax rate
15.78%
14.82%
16.27%
15.94%
Other operating expenses
6.14M
-3.71M
9.62M
1.37M
Net income
69.77M
50.99M
44.70M
56.80M
Net profit margin
40.14%
32.50%
33.26%
40.44%
Earnings per share
-
-
-
-
Interest and investment income
17.16M
12.70M
10.50M
11.83M
Interest expense
-
-81.72K
-23.98K
-82.17K
Net interest expenses
17.16M
12.62M
10.47M
11.75M
Depreciation and amortization charges
-
-
-
-
EBITDA
65.26M
55.91M
39.66M
62.16M
Gain or loss from assets sale
-33.78K
33.78K
52.03K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer